Clinical Research Directory

Inclusion Criteria: * Age: 18-70 years old * Gender: both * Sensitive skin and 30% to 50% with atopic tendency (scored 8-12) * With dry or very dry skin on the body * With presence of itching due to different origins: contact/friction with fabrics, hard water, atopic tendency, dry skin, etc. Exclusion Criteria: * cutaneous marks on the experimental areas, which could interfere with the assessment of skin reactions (pigmentation troubles, scar elements, over-developed pilosity, ephelides and naevi in too great quantity, sunburn), * allergy or reactivity to products of the same category than the tested one, * with history of malignant melanomas (Dubreullh melanosis…) * unbalanced hormonal treatment, * forecast of initiation of an hormonal treatment or change of the usual hormonal treatment during the study or 3 months before the starting of the study, * forecast of intensive sun or UVA exposure (UV lamps) during the test period, * breast-feeding or pregnancy, * treatment with Vitamin A acid or its derivatives stopped less than 3 months before the beginning of the study, * treatment with anti-stretch, firming, slimming or anti-cellulite products stopped less than 3 months before the beginning of the study, * diet stopped less than 3 months before the beginning of the study, * drugs likely to produce an increase or reduction in body weight, * under anti-cellulite treatment: mesotherapy, electrotherapy, ionisation, ultrasonotherapy, relaxation, acupuncture, hydrotherapy, lymphatic drainage, massage, sauna,…, * neither antibiotic, anti-allergic, anti-inflammatory treatment nor treatment with patent medicines containing Vitamin A acid or its derivatives before and during the study (if therapeutic requirement: exclusion foreseen), * systemic disorders: Cardiovascular, pulmonary, digestive, neurologic, psychiatric, genital, urinary, haematological, endocrine * individuals who have undergone a bilateral mastectomy with lymph node removal, a unilateral mastectomy with lymph node removal within the last year, or a bilateral axillary lymph node removal, * individuals with a history of immune deficiency or auto-immune disease, treated for malignancy within 6 months prior to enrollment or who are currently under treatment for asthma or diabetes, * forecast of vaccination during the test period or last vaccination within 3 weeks before the study